ArticleFrontiers in allergy2026

Depemokimab demonstrates efficacy in patients with type 2 asthma with comorbid CRSwNP: Phase III SWIFT-1/-2 analysis.

Enrico Heffler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.